This nanoparticle was built by Irvine and his colleagues two
years ago. The protein fragments that make up the vaccine are encased in a
sphere made of several layers of lipids that are chemically "stapled"
to one another, making the particles more durable inside the body. This allows
the particles to resist disintegration once they reach the lungs. With this
sturdier packaging, the protein vaccine remains in the lungs long enough for
immune cells lining the surface of the lungs to grab them and deliver them to T
cells. Activating T cells is a critical step for the immune system to form a
memory of the vaccine particles so it will be primed to respond again during an
infection.
The particles also hold promise for delivering cancer
vaccines, which stimulate the body's own immune system to destroy tumors. To test this, the researchers first implanted the mice with
melanoma tumors that were engineered to express ovalbumin, a protein found in
egg whites. Three days later, they vaccinated the mice with ovalbumin. They
found that mice given the nanoparticle form of the vaccine completely rejected
the tumors, while mice given the uncoated vaccine did not.
The MIT scientists keep working on the development of this
nanoparticle vaccine in order to use it to cure some other sickness.
No hay comentarios.:
Publicar un comentario